NTG Clarity Networks (NCI) Trading Down 33.3%

Share on StockTwits

NTG Clarity Networks Inc. (CVE:NCI) fell 33.3% on Tuesday . The stock traded as low as C$0.02 and last traded at C$0.02. 310,000 shares were traded during trading, an increase of 299% from the average session volume of 77,750 shares. The stock had previously closed at C$0.03.

The firm has a market capitalization of $1.74 million and a price-to-earnings ratio of 6.67.

TRADEMARK VIOLATION WARNING: “NTG Clarity Networks (NCI) Trading Down 33.3%” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be accessed at https://www.tickerreport.com/banking-finance/4248737/ntg-clarity-networks-nci-trading-down-33-3.html.

NTG Clarity Networks Company Profile (CVE:NCI)

NTG Clarity Networks Inc provides telecommunications engineering, information technology, networking, and related software solutions in Canada and Egypt. Its products include StageEM, an enterprise solution that covers project portfolio management, demand and capacity, analytic and dashboard, and decision-making using real-time data; Workflow Management solution, which enables organizations to design, deploy, execute, monitor, and analyze their business processes; Network Inventory Management solution that covers networks, services, and resources for organizations; and Partner Relationship Management solution covers the value chain of partnerships and enables vendors to manage their strategic partners.

Recommended Story: Why do corrections happen?

Receive News & Ratings for NTG Clarity Networks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NTG Clarity Networks and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Ultragenyx Pharmaceutical  Stock Rating Upgraded by Zacks Investment Research
Ultragenyx Pharmaceutical Stock Rating Upgraded by Zacks Investment Research
Brokerages Set TapImmune Inc.  Target Price at $9.25
Brokerages Set TapImmune Inc. Target Price at $9.25
Q4 2019 EPS Estimates for Franklin Electric Co.  Increased by Analyst
Q4 2019 EPS Estimates for Franklin Electric Co. Increased by Analyst
Eaton Vance Corp  Stake Increased by IFM Investors Pty Ltd
Eaton Vance Corp Stake Increased by IFM Investors Pty Ltd
OGE Energy Corp.  Stake Lowered by IFM Investors Pty Ltd
OGE Energy Corp. Stake Lowered by IFM Investors Pty Ltd
Old Republic International Co.  Holdings Cut by Wedbush Securities Inc.
Old Republic International Co. Holdings Cut by Wedbush Securities Inc.


© 2006-2019 Ticker Report